Skip to search formSkip to main contentSkip to account menu

Thromboxane B2

Known as: Thromboxa-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,13E,15S)-, B2, Thromboxane, Thromboxane B2 [Chemical/Ingredient] 
An eicosanoid and biologically inactive metabolite of thromboxane A2. Thromboxane B2 is released during anaphylaxis. As thromboxane A2 has a short… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Background—We studied whether aspirin resistance, defined as failure of suppression of thromboxane generation, increases the risk… 
Highly Cited
1998
Highly Cited
1998
Apoptosis in vivo is followed almost inevitably by rapid uptake into adjacent phagocytic cells, a critical process in tissue… 
Highly Cited
1998
Highly Cited
1996
Highly Cited
1996
BACKGROUND Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with… 
Highly Cited
1992
Highly Cited
1992
BACKGROUND Constriction of small pulmonary arteries and arterioles and focal vascular injury are features of pulmonary… 
Highly Cited
1990
Highly Cited
1990
It has been suggested that platelet hyperreactivity in patients with diabetes mellitus is associated with increased platelet… 
Highly Cited
1983
Highly Cited
1983
To assess the pharmacologic effects of aspirin on endogenous prostacyclin and thromboxane biosynthesis, 2,3-dinor-6-keto PGF1… 
Highly Cited
1980
Highly Cited
1975
Highly Cited
1975
An unstable [t1/2 at 37 degrees = 32 +/- 2 (SD) sec] intermediate, thromboxane A2, was detected in the conversion of…